Treatment with genetically modified stem cells helped rats with a paralyzing disease live significantly longer, U.S. researchers said on Monday in a finding that could one day help humans.
Rats with ALS that were treated with the gene-engineered stem cells lived 28 days longer than untreated mice, the researchers told a conference.